Contact urticaria syndrome: a comprehensive review

Giménez Arnau, Anna Maria; Pesqué, David; Maibach, Howard

doi:http://dx.doi.org/10.1007/s13671-022-00379-0

Contact urticaria syndrome: a comprehensive review

Citation

Giménez-Arnau AM, Pesqué D, Maibach HI. Contact urticaria syndrome: a comprehensive review. Curr Dermatol Rep. 2022; 11(4): 194-201. DOI: 10.1007/s13671-022-00379-0

Abstract

Purpose of review: contact urticaria syndrome includes contact urticaria and protein contact dermatitis. Underreport, underdiagnosis, or misdiagnosis of entities within the contact urticaria syndrome is believed to be common, especially in the occupational setting. This review provides a structured overview of the entities comprised in this syndrome as well as the diagnostic work-up and management strategies. Recent findings: contact urticaria syndrome has been increasingly described due to personal protective equipment and hand sanitizers in the context of the COVID-19 pandemic. The use of legal cannabis products has led to a rise in occupational cases of contact urticaria to cannabis. A declining trend in the evolution of contact urticaria has been described for natural rubber latex allergy due to the use of synthetic gloves. Prick test has been proposed as a screening method, particularly if multiple products are to be tested, instead of the classical sequential scheme. Summary: physicians should be aware of the growing number of culprit agents leading to contact urticaria syndrome. Clinical presentation may be challenging since it includes immediate urticaria and/or eczema and even more generalized reactions. Diagnosis requires a high degree of suspicion, detailed occupational history, and complementary tests, including skin testing. The best treatment is to avoid contact with the culprit agent and to implement preventive measures.